Trial Details

COMPLETED
Basic Information
Clinical ID c1176
Identifier NCT04596293
Trial Title Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: BBT-401-1S or Placebo
Participant Information
Sponsor Bridge Biotherapeutics, Inc.
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-06-11
Primary Completion Date 2022-05-17
Completion Date 2022-07-12